Keywords: novartis, alnylam, enter, rnai, avian, flu, accord

Novartis and Alnylam enter RNAi avian flu R&D accord

Article | 27 February 2006

Print This

Swiss drug major Novartis and the USA's Alnylam Pharmaceuticals have entered a new collaboration to develop therapeutics for pandemic flu ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in